BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33735416)

  • 1. A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol.
    Russo C; Caponnetto P; Cibella F; Maglia M; Alamo A; Campagna D; Frittitta L; Di Mauro M; Leotta C; Mondati E; Krysiński A; Franek E; Polosa R
    Intern Emerg Med; 2021 Oct; 16(7):1823-1839. PubMed ID: 33735416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV.
    Ashare RL; Thompson M; Serrano K; Leone F; Metzger D; Frank I; Gross R; Hole A; Mounzer K; Collman RG; Wileyto EP; Schnoll R
    Drug Alcohol Depend; 2019 Jul; 200():26-33. PubMed ID: 31082665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    Russo C; Walicka M; Caponnetto P; Cibella F; Maglia M; Alamo A; Campagna D; Frittitta L; Di Mauro M; Caci G; Krysinski A; Franek E; Polosa R
    JAMA Netw Open; 2022 Jun; 5(6):e2217709. PubMed ID: 35727580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varenicline versus placebo for waterpipe smoking cessation: a double-blind randomized controlled trial.
    Dogar O; Zahid R; Mansoor S; Kanaan M; Ahluwalia JS; Jawad M; Siddiqi K
    Addiction; 2018 Dec; 113(12):2290-2299. PubMed ID: 30187978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial.
    Ebbert JO; Hughes JR; West RJ; Rennard SI; Russ C; McRae TD; Treadow J; Yu CR; Dutro MP; Park PW
    JAMA; 2015 Feb; 313(7):687-94. PubMed ID: 25688780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial.
    Gray KM; Baker NL; McClure EA; Tomko RL; Squeglia LM; Saladin ME; Carpenter MJ
    JAMA Pediatr; 2019 Dec; 173(12):1146-1153. PubMed ID: 31609433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial.
    Chen LS; Baker TB; Miller JP; Bray M; Smock N; Chen J; Stoneking F; Culverhouse RC; Saccone NL; Amos CI; Carney RM; Jorenby DE; Bierut LJ
    Clin Pharmacol Ther; 2020 Dec; 108(6):1315-1325. PubMed ID: 32602170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
    Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
    JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
    Tonstad S; Tønnesen P; Hajek P; Williams KE; Billing CB; Reeves KR;
    JAMA; 2006 Jul; 296(1):64-71. PubMed ID: 16820548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
    Evins AE; Cather C; Pratt SA; Pachas GN; Hoeppner SS; Goff DC; Achtyes ED; Ayer D; Schoenfeld DA
    JAMA; 2014 Jan; 311(2):145-54. PubMed ID: 24399553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.
    Walker N; Smith B; Barnes J; Verbiest M; Kurdziel T; Parag V; Pokhrel S; Bullen C
    Addiction; 2019 Feb; 114(2):344-352. PubMed ID: 30276931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised, placebo-controlled, double-blind, double-dummy, multicentre trial comparing electronic cigarettes with nicotine to varenicline and to electronic cigarettes without nicotine: the ECSMOKE trial protocol.
    Berlin I; Dautzenberg B; Lehmann B; Palmyre J; Liégey E; De Rycke Y; Tubach F
    BMJ Open; 2019 May; 9(5):e028832. PubMed ID: 31129603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
    Ebbert JO; Hatsukami DK; Croghan IT; Schroeder DR; Allen SS; Hays JT; Hurt RD
    JAMA; 2014 Jan; 311(2):155-63. PubMed ID: 24399554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Varenicline Added to Counseling on Smoking Cessation Among African American Daily Smokers: The Kick It at Swope IV Randomized Clinical Trial.
    Cox LS; Nollen NL; Mayo MS; Faseru B; Greiner A; Ellerbeck EF; Krebill R; Tyndale RF; Benowitz NL; Ahluwalia JS
    JAMA; 2022 Jun; 327(22):2201-2209. PubMed ID: 35699705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial.
    Rigotti NA; Pipe AL; Benowitz NL; Arteaga C; Garza D; Tonstad S
    Circulation; 2010 Jan; 121(2):221-9. PubMed ID: 20048210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Varenicline for Cigarette Reduction Before Quitting in Japanese Smokers: A Subpopulation Analysis of the Reduce to Quit Trial.
    Nakamura M; Abe M; Ohkura M; Treadow J; Yu CR; Park PW
    Clin Ther; 2017 Apr; 39(4):863-872. PubMed ID: 28365035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.